Partner With Us
The 9th Liquid Biopsy for Precision Oncology Summit provided an end-to-end perspective on liquid biopsy-enhanced drug trials, and was the ideal platform to showcase your solutions as we brought together the crème de la crème of liquid biopsy professionals. Our audience of over 250 decision-makers from leading biopharma were seeking to partner with companies with capabilities in assay development, diagnostics, AI, and bioinformatic solutions to help them drive precision oncology forward.
You could have presented your cutting-edge technologies and services, taken part in a panel discussion, exhibited your capabilities at a booth, or pushed the boat out and discussed bespoke partnership packages with unique deliverables to make your mark and stand out amongst your competitors.
Showcasing your Pioneering Solutions
Presenting your cutting-edge technologies and diagnostic services to a focused audience of senior decision makers. With strategic exposure pre- and post-conference, differentiating your offerings from your competitors and seizing branding opportunities to amplify your visibility and cement your position as a leader in advancing cancercare through precision medicine.
Gaining Strategic Market Insights
Staying ahead in the evolving and competitive liquid biopsy landscape. Understanding key priorities for biopharma and precision medicine leaders seeking innovative tools to improve MRD detection, real-time monitoring, and patient outcomes. Positioning your solutions to meet the latest regulatory demands and scientific standards in this critical field.
Forging High-Impact Collaborations
Engaging with influential stakeholders from biopharma, diagnostics, and academic institutions within the liquid biopsy field. Dedicated intimate networking sessions, including speed networking and targeted discussions, fostering unparalleled opportunities to create partnerships that drive progress in cancer diagnostics and patient care, with a shared goal of expanding precision oncology access.
Who Did You Meet?
